Incontinence and Ostomy Care Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Incontinence and Ostomy Care Products Market is projected to expand from a valuation of USD 19.66 Billion in 2025 to USD 26.12 Billion by 2031, registering a CAGR of 4.85%. This industry encompasses medical devices and absorbent solutions specifically engineered to address involuntary bladder or bowel functions and support patients with surgical stomas. Major product categories include catheters, protective hygiene supplies, and ostomy pouches designed for daily maintenance. The primary factors fueling market trajectory are the aging global population and the increasing prevalence of chronic conditions like inflammatory bowel disease and urological disorders, which create a steady, non-discretionary demand for these essential care solutions.

A major obstacle hindering market consistency is the high rate of peristomal skin issues and infections, which can deter regular product use and elevate treatment complexities. Producers face the difficult task of ensuring strong adhesion and skin safety while keeping costs manageable for users. Data from the United Ostomy Associations of America in 2024 indicates that roughly 100,000 new patients undergo ostomy surgery in the United States each year. This continuous stream of new patients underscores the critical need for reliable therapeutic products to accommodate this expanding demographic.

Market Drivers

The escalating growth of the global geriatric population acts as a primary engine for the Incontinence and Ostomy Care Products Market, as aging leads to physiological changes that heighten susceptibility to bladder and bowel incontinence. As people get older, urinary system structures often degrade, requiring the long-term use of catheters, absorbents, and hygiene products to uphold daily living standards. This demographic trend guarantees a growing patient pool necessitating chronic management, specifically among the oldest individuals who demand intensive support. According to the United Nations' "World Population Prospects 2024" released in July 2024, the number of people aged 80 and above is predicted to hit 265 million by the mid-2030s, forming a rapidly enlarging consumer group for daily care necessities.

Concurrently, the increasing incidence of inflammatory bowel diseases and colorectal cancer is driving the uptake of specialized ostomy devices. Surgeries for these critical conditions frequently lead to stoma formation, creating an immediate and permanent requirement for ostomy barriers, bags, and skincare accessories. The rising diagnosis rates of these chronic diseases are broadening the market scope beyond elderly demographics, fueling the need for advanced postoperative aids. As stated in the American Cancer Society's "Cancer Facts & Figures 2024" from January 2024, approximately 152,810 new colorectal cancer cases are anticipated in the United States for that year. This clinical demand supports strong financial results for major producers; for example, Coloplast reported in November 2024 within its "Annual Report 2023/24" that its Ostomy Care division achieved 7% organic growth, highlighting the essential nature of these products.

Market Challenges

The frequent occurrence of peristomal skin complications and infections constitutes a significant barrier to the stability and expansion of the Global Incontinence and Ostomy Care Products Market. These physical issues, which span from irritant dermatitis to serious fungal infections, undermine the performance of adhesives and absorbents, causing leakage and shortened usage durations. When patients encounter these negative outcomes, they frequently lose faith in specific products, leading to lower compliance and frequent switching between brands. This instability interrupts the steady revenue flows manufacturers depend on and compels companies to allocate substantial assets toward solving fundamental biocompatibility issues rather than focusing on new innovations.

Additionally, the financial strain associated with treating these complications restricts the widespread use of high-end care solutions. The necessity for supplementary treatments and more frequent product replacements drives up the total cost of care, placing a burden on both personal finances and healthcare systems. According to the United Ostomy Associations of America in 2024, 56% of patients who faced alterations in their pouching regimens - often triggered by skin complications - noted a rise in healthcare expenditures and out-of-pocket costs. This economic stress impedes market growth, as funds are depleted by managing complications instead of being invested in durable, superior management systems.

Market Trends

The incorporation of smart sensor technology is transforming patient care by mitigating the physical and psychological stress associated with leakage anxiety. Developers are integrating digital connectivity into incontinence and ostomy devices, enabling real-time tracking of barrier status and saturation levels through mobile applications. This technological advancement transitions the market from reactive containment to proactive oversight, notably decreasing the likelihood of skin issues and boosting user assurance. In its "Annual Report 2024/25" from November 2025, Coloplast noted the commercial rollout of its Heylo digital leakage notification system, which is now fully reimbursed and accessible to patients in the United Kingdom, signifying a key milestone in the uptake of connected health solutions.

At the same time, the transition toward biodegradable and sustainable materials is prompting manufacturers to restructure product formulations and supply chains amidst environmental observation. Innovation is focusing on substituting fossil-fuel-based plastics with renewable plant-derived alternatives and attaining carbon-neutral manufacturing without sacrificing the clinical effectiveness needed for high-absorbency hygiene items. This movement is demonstrated by ambitious corporate sustainability goals and external verifications of environmental stewardship. For instance, Drylock Technologies stated in its "Sustainability Report 2024-2025" in September 2025 that it preserved CO2 neutrality across all global production facilities and secured an EcoVadis Platinum rating, positioning it within the top 1% of companies evaluated for sustainability worldwide.

Key Players Profiled in the Incontinence and Ostomy Care Products Market

• Coloplast A/S
• Essity AB
• Kimberly-Clark Corp
• B Braun SE
• Hollister Inc.
• Unicharm Corp
• ConvaTec Group PLC
• Welland Medical Ltd.
• Domtar Corp
• Salts Healthcare Ltd.

Report Scope

In this report, the Global Incontinence And Ostomy Care Products Market has been segmented into the following categories:

Incontinence And Ostomy Care Products Market, by Type:

• Incontinence Care Products (Absorbents
• Incontinence Bags
• Others)
• Ostomy Care Products (Ostomy Bags
• Deodorants
• Skin Barriers
• Irrigation Products)

Incontinence And Ostomy Care Products Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Incontinence And Ostomy Care Products Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.